Dendritic cell based therapy of cancer

Advances in Experimental Medicine and Biology

Volumn 417, Issue , 1997, Pages 551-569

  Lotze, Michael T ^a,b   Shurin, Michael ^a   Davis, Ian ^a   Amoscato, Andrew ^a   Storkus, Walter J ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CYTOKINE; HEAT SHOCK PROTEIN; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELANOMA ANTIGEN; TUMOR ANTIGEN;

ADOPTIVE TRANSFER; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENETIC ENGINEERING; HELPER CELL; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CELL COMMUNICATION; CELL MOVEMENT; CYTOKINES; DENDRITIC CELLS; DNA, NEOPLASM; GENETIC ENGINEERING; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOTHERAPY; MICE; NEOPLASMS; PEPTIDES; T-LYMPHOCYTES;

ANIMALIA;

EID: 0030774326     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9966-8_91     Document Type: Article

References (39)

1. Robbins PF, El - Gamil M, Kawakami, Y, Rosenberg SA. Recognition of tyrosinase by tumor - infiltrating lymphocytes from a patient responding to immunotherapy. 1994; Cancer Res54:3124-3126.
2. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakkaguchi K, Appella E, Yanelli JR, Adema GJ, Kimi T, Rosenberg SA. Identification of melanoma antigens recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection . 1994; Proc Natl Acad Sci 91:6458-6462.
3. Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van Den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. 1991; Science 254:1643-1047.
4. Traversari C, van der Bruggen P, Luescher IF, et al.: A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T - lymphocytes directed against tumour antigen MZ2-E. J Exp Med 1992: 176:1453-1458
5. Van der Bruggen P, Szikora J-P, Boel, P, Wildmann C, Somville, M, Sensi M, Boon T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*16018. 1994. Eur J Immunol 24:2134-2140.
6. Zakut R, Topalian SL, Kawakami Y, Mancini M, Eliyahu S, Rosenberg SA. Differential expression of MAGE-1,-2, -3 messenger RNA in transformed and normal cell lines. 1993; Cancer Res 53:54-47.
7. Shamamian P, Mancini M, Kawakami Y, et al.: Recognition of neuroectodermal tumors by melanoma -specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crest. Cancer Immunol Immunother 1994; 39:73-79
8. Gaugler B, Van den Eynde B, van der Bruggen P. Romerao P, Gaforio J J , De Plaen E, Lethe B, Brasseur F, Boon T . Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. 1994; J Exp Med 179:921-930.
9. Van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boel P, De Smet C, Traversari C, Townsend A, Boon T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. 1994. Eur J Immunol 24:3038-3043.
10. Boel-P; Wildmann-C; Sensi-ML; Brasseur-R; Renauld-JC; Coulie-P; Boon-T; van-der-Bruggen-P BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. 1995. Immunity. 2: 167-75
11. Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T. A new family of genes coding for an antigen recognized by cytolytic T lymphocytes on a human melanoma. J Exp Med 182:689-698, 1995.
12. Brichard V, Van Pel A, Wolfel T, Wolfel C, De Plaen, E. Lethe B, Coulie P. Boon T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas . 1993; J Exp Med 178:489-495.
13. Wolfel T. Van Pel, A, Brichard V, Schneider J, Seliger B, Meyer zum Buschenfelde K-H, Boon T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. 1994; Eur J Immunol 24:759-764.
14. Wang R-F, Robbins PF, Kawakami Y, Kang X-Q, Rosenberg SA. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31 - restricted tumor - infiltrating lymphocytes. 1995; J Exp Med 181:799-804.
15. Wang R-F, Robbins PF, Kawakami Y, Rosenberg SA. A novel human cancer antigen resulting from translation of an alternative open reading frame of TRP-1. Science, in press.
16. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. 1994; Proc Natl Acad Sci 91:3515-3519.
17. Coulie PG, Brichard V, VanPel A, Wolfel T, Schneider J, Traversari C, Mattel S, De Plaen E, Lurquin C, Szikora J-P, Renauld J-C, Boon T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. 1994; J Exp Med 180:35-42.
18. Castelli C, Storkus WJ, Maeurer MJ, Martin DM, Huang EC, Pramanik BN, Nagabhushan TL, Parmiani G, Lotze MT. Mass spectrometric identification of a naturally - processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes. 1995; J Exp Med 181:363-368.
19. Bakker ABH, Schreurs MWJ, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG. Melanocyte lineage - specific antigen gp100 is recognized by melanoma derived tumor infiltrating lymphocytes. 1994; J Exp Med 179:1005-1009.
20. Cox AL, Skipper J , Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CL. Identification of a peptide recognized by five melanoma - specific human cytotoxic T cell lines. 1994; Science 264:716-719.
21. Anichini A, Maccalli C, Mortarini R, Salvi S, Mazzocchi A, Squarcina P, Herlyn M, Parmiani G. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2 restricted cytotoxic T cell clones from melanoma patients. 1993. J Exp Med 177:265-272.
22. Egner W, McKenzie JL, Smith SM, Beard ME, Hart DN. Identification of potent mixed leukocyte reaction-stimulatory cells in human bone marrow. Putative differentiation stage of human blood dendritic cells. Journal of Immunology 1993;150:3043-3053.
23. Inaba K., Witmer-Pack M., Inaba M. et al. The tissue distribution of B7-2 costimulator in mice:abundant expression of dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849-1860, 1994.
24. Kämpgen, Koch F, Heufler C, Eggert A, Gill LL, Gillis S, Dower SK, Romani N, Schuler G. Understanding the dendritic cell lineage through a study of cytokine receptors. Journal of Experimental Medicine 1994;179:1767-1776.
25. Zhou L-J, Tedder TF. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. Blood 1995;86:3295-3301.
26. Turcovski-Corrales SM, Fenton RG, Peltz G, Taub DD. CD28:B7 interactions promote T cell adhesion. European Journal of Immunology 1995;25:3087-3093.
27. Péguet-Navarro J, Dalbiez-Gauthier C, Rattis FM, Van Kooten C, Banchereau J. Schmitt D. Functional expression of CD40 antigen on human epidermal Langerhans cells. Journal of Immunology 1995;155:4241-4247.
28. Young JW, Inaba K. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. Journal of Experimental Medicine 1996:183:7-11.
29. Paglia P, Chiodoni C. Rodolfo M, Colombo MR. Murine dendritic cells loaded in vitro iwth soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. Journal of Experimental Medicine 1996;183:317-322.
30. Knight SC, Hunt R, Dore C, Medawar PB. Influence of dendritic cells on tumor growth. Proceedings of the National Academy of Science 1985;82:4495-4497.
31. Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzzi, C., Falo, L.D., Melief, C.J., Ildstad, ST., Kast, W.M., DeLeo, A., and Lotze, M.T. Bone marrow derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic anti-tumor immunity. Nature Med. 1: 1297-1302, 1995.
32. Celluzzi, C.M., Mayordomo, J.I., Strokus, W.J., Lotze, M.T., and Falo, L.D. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183: 283-288, 1996.
33. Flamand, V. Murine Dendritic Cells Pulsed In Vitro with Tumor Antigen Induce Tumor Resistance In Vivo, Eur. J. Immunol. 23: 605-610, 1994.
34. Zitvogel, L., J. I. Mayordomo, T.Tjandrawan, A. B. DeLeo, M. R. Clarke, M. T. Lotze, and W. J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell-associated cytokines .J. Exp. Med. 183:87-97.
35. Zou J-P, Shimizu J, Ikegame K, Takiuchi H, Fujiwara H, Hamaoka T. Tumor-immuotherapy with the use of tumor-antigen:pulsed antigen-presenting cells. Cancer Immunology Immunotherapy 1992;35:1-6.
36. Morimoto RI. Cells in stress: transcriptional activation of heat shock genes. Science 259: 1409-1410, 1993.
37. Georgopoulos C and Welch WJ. Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 9: 601-634, 1993.
38. Mariethoz E, Tacchini-Cottier F, Jacquier-Sarlin M, Sinclair F and Polla BS. Exposure of monocytes to heat shock does not increase class II expression but modulates antigen-dependent T cell responses. Int Immunol 6: 925-930, 1994.
39. Polla BS and Mariethoz E. More evidence for a case for chaperones in antigen processing. Immunol Today 13: 421-422, 1992.